Nurix Therapeutics Insider Trades
NASDAQ: NRIXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 34 · $3.74M
- Shares bought / sold
- 0 / 190.57K
- Net activity
- Net selling $3.7 million
Nurix Therapeutics insider activity
Over the last 12 months, Nurix Therapeutics insiders reported 76 transactions on SEC Form 4: 0 open-market purchases and 34 sales. Insiders bought $0 and sold $3.7 million worth of stock, for net insider selling of $3.7 million. The largest seller was Ring Christine, with $2.6 million in reported sales.
The most recent filing shows Ring Christine (Chief Legal Officer) reporting a transaction in 5,786 shares at $8.72 on Oct 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NRIX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
NRIX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 2, 2026 | Ring ChristineChief Legal Officer | Sale | 5,786 | $134.15K | Form 4 |
| Oct 2, 2026 | Ring ChristineChief Legal Officer | Option exercise | 5,786 | $50.45K | Form 4 |
| Sep 2, 2026 | Ring ChristineChief Legal Officer | Sale | 400 | $10.65K | Form 4 |
| Sep 2, 2026 | Ring ChristineChief Legal Officer | Sale | 5,387 | $138.42K | Form 4 |
| Sep 2, 2026 | Ring ChristineChief Legal Officer | Option exercise | 5,787 | $50.46K | Form 4 |
| Sep 1, 2026 | Hansen GwennChief Scientific Officer | Sale | 1,452 | $36.98K | Form 4 |
| Sep 1, 2026 | Hansen GwennChief Scientific Officer | Option exercise | 1,452 | $2.70K | Form 4 |
| Aug 5, 2026 | Hansen GwennChief Scientific Officer | Sale | 4,356 | $108.90K | Form 4 |
| Aug 5, 2026 | Hansen GwennChief Scientific Officer | Option exercise | 4,356 | $8.10K | Form 4 |
| Aug 4, 2026 | van Houte HansChief Financial Officer | Sale | 2,967 | $73.13K | Form 4 |
| Aug 4, 2026 | van Houte HansChief Financial Officer | Sale | 1,794 | $42.86K | Form 4 |
| Aug 4, 2026 | Hansen GwennChief Scientific Officer | Sale | 2,611 | $64.34K | Form 4 |
| Aug 4, 2026 | Hansen GwennChief Scientific Officer | Sale | 1,500 | $35.80K | Form 4 |
| Aug 3, 2026 | Ring ChristineChief Legal Officer | Sale | 16,589 | $382.36K | Form 4 |
| Aug 3, 2026 | Ring ChristineChief Legal Officer | Option exercise | 5,787 | $50.46K | Form 4 |
| Jul 30, 2026 | Hansen GwennChief Scientific Officer | Sale | 3,847 | $89.95K | Form 4 |
| Jul 30, 2026 | Hansen GwennChief Scientific Officer | Option exercise | 3,572 | — | Form 4 |
| Jul 30, 2026 | Hansen GwennChief Scientific Officer | Option exercise | 2,858 | — | Form 4 |
| Jul 30, 2026 | Hansen GwennChief Scientific Officer | Option exercise | 3,750 | — | Form 4 |
| Jul 30, 2026 | Ring ChristineChief Legal Officer | Sale | 3,847 | $89.95K | Form 4 |
| Jul 30, 2026 | Ring ChristineChief Legal Officer | Option exercise | 3,572 | — | Form 4 |
| Jul 30, 2026 | Ring ChristineChief Legal Officer | Option exercise | 2,858 | — | Form 4 |
| Jul 30, 2026 | Ring ChristineChief Legal Officer | Option exercise | 3,750 | — | Form 4 |
| Jul 30, 2026 | van Houte HansChief Financial Officer | Sale | 2,845 | $66.52K | Form 4 |
| Jul 30, 2026 | van Houte HansChief Financial Officer | Option exercise | 3,572 | — | Form 4 |
| Jul 30, 2026 | van Houte HansChief Financial Officer | Option exercise | 2,858 | — | Form 4 |
| Jul 30, 2026 | van Houte HansChief Financial Officer | Option exercise | 3,750 | — | Form 4 |
| Jul 2, 2026 | Ring ChristineChief Legal Officer | Sale | 11,008 | $259.37K | Form 4 |
| Jul 2, 2026 | Ring ChristineChief Legal Officer | Option exercise | 5,787 | $50.46K | Form 4 |
| Jul 2, 2026 | Ring ChristineChief Legal Officer | Option exercise | 5,221 | $9.71K | Form 4 |
| Jun 25, 2026 | Ring ChristineChief Legal Officer | Sale | 28,935 | $580.51K | Form 4 |
| Jun 25, 2026 | Ring ChristineChief Legal Officer | Option exercise | 15,602 | $136.05K | Form 4 |
| Jun 25, 2026 | Ring ChristineChief Legal Officer | Option exercise | 13,333 | $96.80K | Form 4 |
| Jun 25, 2026 | Hansen GwennChief Scientific Officer | Sale | 5,394 | $107.88K | Form 4 |
| Jun 2, 2026 | Ring ChristineChief Legal Officer | Sale | 8,148 | $135.25K | Form 4 |
| Jun 2, 2026 | Ring ChristineChief Legal Officer | Option exercise | 3,422 | $6.36K | Form 4 |
| May 5, 2026 | van Houte HansChief Financial Officer | Sale | 582 | $10.00K | Form 4 |
| May 5, 2026 | van Houte HansChief Financial Officer | Sale | 13,473 | $223.32K | Form 4 |
| May 4, 2026 | Ring ChristineChief Legal Officer | Sale | 8,148 | $138.21K | Form 4 |
| May 1, 2026 | Ring ChristineChief Legal Officer | Sale | 5,394 | $90.41K | Form 4 |
| Apr 30, 2026 | Hansen GwennChief Scientific Officer | Sale | 3,214 | $53.50K | Form 4 |
| Apr 30, 2026 | Hansen GwennChief Scientific Officer | Option exercise | 2,858 | — | Form 4 |
| Apr 30, 2026 | Hansen GwennChief Scientific Officer | Option exercise | 3,750 | — | Form 4 |
| Apr 30, 2026 | Hansen GwennChief Scientific Officer | Option exercise | 2,000 | — | Form 4 |
| Apr 30, 2026 | Ring ChristineChief Legal Officer | Sale | 3,214 | $53.50K | Form 4 |
| Apr 30, 2026 | Ring ChristineChief Legal Officer | Option exercise | 2,858 | — | Form 4 |
| Apr 30, 2026 | Ring ChristineChief Legal Officer | Option exercise | 3,750 | — | Form 4 |
| Apr 30, 2026 | Ring ChristineChief Legal Officer | Option exercise | 2,000 | — | Form 4 |
| Apr 30, 2026 | van Houte HansChief Financial Officer | Sale | 2,388 | $39.75K | Form 4 |
| Apr 30, 2026 | van Houte HansChief Financial Officer | Option exercise | 2,858 | — | Form 4 |
| Apr 30, 2026 | van Houte HansChief Financial Officer | Option exercise | 3,750 | — | Form 4 |
| Apr 30, 2026 | van Houte HansChief Financial Officer | Option exercise | 2,000 | — | Form 4 |
| Apr 2, 2026 | Ring ChristineChief Legal Officer | Sale | 8,148 | $124.15K | Form 4 |
| Mar 2, 2026 | Ring ChristineChief Legal Officer | Sale | 8,148 | $125.79K | Form 4 |
| Feb 9, 2026 | Ring ChristineChief Legal Officer | Sale | 14,261 | $237.62K | Form 4 |
| Feb 3, 2026 | Hansen GwennChief Scientific Officer | Option exercise | 31,333 | $26.32K | Form 4 |
| Jan 30, 2026 | Hansen GwennChief Scientific Officer | Sale | 98 | $1.70K | Form 4 |
| Jan 30, 2026 | Hansen GwennChief Scientific Officer | Sale | 4,797 | $79.55K | Form 4 |
| Jan 30, 2026 | Hansen GwennChief Scientific Officer | Option exercise | 2,859 | — | Form 4 |
| Jan 30, 2026 | Hansen GwennChief Scientific Officer | Option exercise | 3,750 | — | Form 4 |
| Jan 30, 2026 | Hansen GwennChief Scientific Officer | Option exercise | 2,000 | — | Form 4 |
| Jan 30, 2026 | Hansen GwennChief Scientific Officer | Option exercise | 3,207 | — | Form 4 |
| Jan 30, 2026 | Ring ChristineChief Legal Officer | Sale | 88 | $1.53K | Form 4 |
| Jan 30, 2026 | Ring ChristineChief Legal Officer | Sale | 4,333 | $71.85K | Form 4 |
| Jan 30, 2026 | Ring ChristineChief Legal Officer | Option exercise | 2,859 | — | Form 4 |
| Jan 30, 2026 | Ring ChristineChief Legal Officer | Option exercise | 3,750 | — | Form 4 |
| Jan 30, 2026 | Ring ChristineChief Legal Officer | Option exercise | 2,000 | — | Form 4 |
| Jan 30, 2026 | Ring ChristineChief Legal Officer | Option exercise | 1,925 | — | Form 4 |
| Jan 30, 2026 | van Houte HansChief Financial Officer | Sale | 73 | $1.27K | Form 4 |
| Jan 30, 2026 | van Houte HansChief Financial Officer | Sale | 3,588 | $59.50K | Form 4 |
| Jan 30, 2026 | van Houte HansChief Financial Officer | Option exercise | 2,859 | — | Form 4 |
| Jan 30, 2026 | van Houte HansChief Financial Officer | Option exercise | 3,750 | — | Form 4 |
| Jan 30, 2026 | van Houte HansChief Financial Officer | Option exercise | 2,000 | — | Form 4 |
| Jan 30, 2026 | van Houte HansChief Financial Officer | Option exercise | 2,887 | — | Form 4 |
| Jan 20, 2026 | Ring ChristineChief Legal Officer | Sale | 3,760 | $69.27K | Form 4 |
| Jan 20, 2026 | Ring ChristineChief Legal Officer | Option exercise | 3,760 | $6.99K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4